Documente Academic
Documente Profesional
Documente Cultură
IN
Narration Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Trailing Best Case Worst Case
Sales - 237.27 342.21 451.66 557.95 659.59 791.32 912.38 1,056.92 1,203.42 1,294.40 1,383.90 1,382.84
Expenses - 180.55 255.59 353.72 418.85 503.64 581.59 674.57 792.92 909.76 958.60 1,024.88 1,039.72
Operating Profit - 56.72 86.62 97.94 139.10 155.95 209.73 237.81 264.00 293.66 335.80 359.02 343.12
Other Income - 2.39 2.17 3.10 7.54 12.36 19.77 27.25 31.22 45.95 54.90 - -
Depreciation - 13.60 19.83 20.40 27.23 28.19 28.28 27.54 33.06 38.22 54.00 54.00 54.00
Interest - 0.78 2.53 0.44 0.20 0.40 0.50 0.70 0.84 0.84 7.90 7.90 7.90
Profit before tax - 44.73 66.43 80.20 119.21 139.72 200.72 236.82 261.32 300.55 328.80 297.12 281.22
Tax - 15.18 21.26 24.55 38.94 43.28 67.48 81.23 89.57 100.08 95.20 29% 29%
Net profit - 29.12 44.71 55.13 79.59 95.68 132.19 154.59 170.73 199.18 232.20 211.09 199.79
EPS - 85.86 133.28 164.33 14.83 17.51 15.99 18.61 20.49 23.90 27.86 25.33 23.97
Price to earning 57.75 51.99 42.77 43.70 56.28 56.28 48.68
Price - - - - - - 923.30 967.55 876.30 1,044.30 1,567.90 1,425.37 1,167.07
RATIOS:
Dividend Payout 0.00% 19.13% 19.26% 9.40% 7.17% 8.76% 15.33% 16.12% 21.96% 25.10%
OPM 0.00% 23.91% 25.31% 21.68% 24.93% 23.64% 26.50% 26.06% 24.98% 24.40% 25.94%
Narration Jun-17 Sep-17 Dec-17 Mar-18 Jun-18 Sep-18 Dec-18 Mar-19 Jun-19 Sep-19
Sales 249.30 278.10 262.70 266.80 292.30 317.50 292.50 301.10 335.20 365.60
Expenses 183.80 200.20 206.10 202.80 217.30 230.70 226.90 234.90 240.10 256.70
Operating Profit 65.50 77.90 56.60 64.00 75.00 86.80 65.60 66.20 95.10 108.90
Other Income 7.50 7.70 7.10 8.90 9.40 10.90 12.20 13.50 14.40 14.80
Depreciation 6.90 7.50 8.00 10.70 8.80 9.40 9.60 10.40 16.30 17.70
Interest 0.10 0.30 0.20 0.20 0.20 0.20 0.30 0.10 3.80 3.70
Profit before tax 66.00 77.80 55.50 62.00 75.40 88.10 67.90 69.20 89.40 102.30
Tax 21.60 26.90 19.20 21.90 25.70 30.80 21.80 21.80 30.30 21.30
Net profit 44.10 50.60 36.30 40.00 49.40 56.90 45.80 47.10 58.80 80.50
OPM 26% 28% 22% 24% 26% 27% 22% 22% 28% 30%
DR LAL PATHLABS LTD SCREENER.IN
Narration Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Mar-19
Equity Share Capital - 3.39 3.35 3.36 53.68 54.63 82.68 83.07 83.33 83.34
Reserves - 87.79 110.95 157.03 151.18 259.82 423.94 512.45 733.76 889.92
Borrowings - 19.64 0.01 0.38 0.87 - - - - -
Other Liabilities - 59.32 63.29 108.92 146.58 161.87 119.69 96.28 100.73 120.64
Total - 170.14 177.60 269.69 352.31 476.32 626.31 691.80 917.82 1,093.90
Net Block - 112.04 108.29 126.55 139.83 150.08 165.64 152.43 207.52 208.66
Capital Work in Progress - 0.32 6.22 0.52 0.17 0.95 4.09 17.51 9.56 3.44
Investments - 1.01 4.77 54.77 8.59 37.92 64.32 106.08 144.80 184.78
Other Assets - 56.77 58.32 87.85 203.72 287.37 392.26 415.78 555.94 697.02
Total - 170.14 177.60 269.69 352.31 476.32 626.31 691.80 917.82 1,093.90
Working Capital - -2.55 -4.97 -21.07 57.14 125.50 272.57 319.50 455.21 576.38
Debtors - 9.69 14.33 19.79 25.16 30.96 36.31 41.80 41.16 53.22
Inventory - 7.75 6.23 8.63 11.66 14.28 14.52 17.91 27.34 28.54
Debtor Days - 14.91 15.28 15.99 16.46 17.13 16.75 16.72 14.21 16.14
Inventory Turnover - 30.62 54.93 52.34 47.85 46.19 54.50 50.94 38.66 42.17
Return on Equity 32% 39% 34% 39% 30% 26% 26% 21% 20%
Return on Capital Emp 26% 44% 50% 37% 31% 26% 27% 21% 20%
DR LAL PATHLABS LTD SCREENER.IN
Mar-08 Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Mar-19
CFO - - 41.78 68.13 88.13 97.96 121.77 158.54 171.31 197.07 218.54
CFI - - -18.59 -26.26 -64.01 -89.30 -113.45 -163.49 -137.11 -172.28 -99.74
CFF - - -22.15 -38.34 -14.79 -10.20 -0.80 0.36 -32.26 12.51 -55.26
Net Cash Flow - - 1.04 3.53 9.33 -1.54 7.52 -4.59 1.94 37.30 63.54
Last 5 Year Return Moving Average 09-14 10-15 11-16 12-17 13-18 14-19
Total Assets as on beginning (Invested Capital) - 170.14 177.60 269.69 352.31
Total Distribution upto the end of Calculation Period 95.42 102.00 78.09 63.65 35.15 78.86
Total Assets (Invested Capital) including Distribution as on End of the period 447.73 578.32 704.40 755.45 952.97 1,172.76
Annualized Holding Period Return #DIV/0! #DIV/0! 32.9% 33.6% 28.7% 27.2%
Do Not Delete
Cash Released
CFO minus CFI
DR LAL PATHLABS LTD SCREENER.IN
Risk Free Rate assumed 6.05% Change in other Sheet, Do not Change here
Free Cash Flow Measure Cash Released Change in other Sheet, Do not Change here
Mar-08 Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Mar-19
CFO - - 41.78 68.13 88.13 97.96 121.77 158.54 171.31 197.07 218.54
CFI - - -18.59 -26.26 -64.01 -89.30 -113.45 -163.49 -137.11 -172.28 -99.74
CFF - - -22.15 -38.34 -14.79 -10.20 -0.80 0.36 -32.26 12.51 -55.26
Net Cash Flow - - 1.04 3.53 9.33 -1.54 7.52 -4.59 1.94 37.30 63.54
Overall Return
Total Assets as on 31/3/08 411.00
Total Assets including Distribution as on March-19 1,300.76
Annualized Holding Period Return 11.0%
Average Re-Invest Rate 75.9%
Implied Growth Rate 8.4%
Revenue - 237.27 342.21 451.66 557.95 659.59 791.32 912.38 1,056.92 1,203.42
CFO as a % of Revenue NA NA 17.6% 19.9% 19.5% 17.6% 18.5% 20.0% 18.8% 18.6% 18.2%
Median CFO as a % of Revenue 18.6%
Mar-08 Mar-09 Mar-10 Mar-11
Revenue - - - 237.27
Closing Fixed Asset, Net 0 112.04
Add: Depreciation for the year 0 13.6
Less: Opening Fixed Asset, Net 0 0 0
Fixed Assets Purchased, Net(Purchased minus sold) 0 0 0 125.64
Terminal Year CF
Maintanance M-cap 2,470 19.6% Cap Rate
Growth M-Cap 10,107 80.4% Terminal Year Value
Implied Growth Over Next 10 years 6.1% Run what-if analysis PV of Terminal Year Value
Terminal Year Growth Assumed 3.0% PV of Forecasted Peiod CFs
What if analysis Solver cell -7,363.94 Total EV
% Updside/ (Downside)
Forcasted Period
1 2 3 4 5 6 7 8 9 10
210 223 236 251 266 282 300 318 337 358
0.926 0.857 0.794 0.735 0.681 0.630 0.583 0.540 0.500 0.463
194 191 187 184 181 178 175 172 169 166
369
5.0%
7,375
3,416
1,797
5,213
-58.6%
WIP
-3.0% #VALUE! 2.50
-2.5% #VALUE! #VALUE! Negtive El
-2.0% #VALUE! #VALUE!
-1.5% #VALUE! #VALUE!
-1.0% #VALUE! #VALUE!
-0.5% #VALUE! #VALUE!
0% mid Point
0.5% #VALUE! #VALUE!
1.0% #VALUE! #VALUE! Positive E
1.5% #VALUE! #VALUE!
2.0% #VALUE! #VALUE!
2.5% #VALUE! #VALUE!
3.0% #VALUE! #VALUE!
WACC
2.63
3.02
Mar-10 Mar-11 Mar-12 Mar-13 Mar-14
Sales #DIV/0! 100% 100% 100% 100%
Raw Material Cost #DIV/0! 0% 0% 0% 0%
Change in Inventory #DIV/0! 0% 0% 0% 0%
Power and Fuel #DIV/0! 2% 2% 2% 2%
Other Mfr. Exp #DIV/0! 30% 27% 27% 27%
COGS #DIV/0! 32% 29% 29% 29%
Gross Profit Margin #DIV/0! 68% 71% 71% 71%
Employee Cost #DIV/0! 16% 16% 21% 18%
Selling and admin #DIV/0! 26% 28% 27% 26%
Other Expenses #DIV/0! 2% 2% 2% 3%
Other Income #DIV/0! 1% 1% 1% 1%
EBITDA Margin #DIV/0! 23% 25% 21% 24%
Depreciation #DIV/0! 6% 6% 5% 5%
Interest #DIV/0! 0% 1% 0% 0%
Profit before tax #DIV/0! 19% 19% 18% 21%
Tax #DIV/0! 6% 6% 5% 7%
Net profit #DIV/0! 12% 13% 12% 14%
Sanity Analysis
EBITDA - 57 87 98 139
CFO - 42 68 88 98
Debtor Analysis
Sales - 237 342 452 558
Debtor Balance - 10 14 20 25
Average Debtor - 5 12 17 22
Avg Debtor as % of Sales #DIV/0! 2.04% 3.51% 3.78% 4.03%
Sales Growth 100.0% 30.7% 24.2% 19.1%
Average Debtors Growth #DIV/0! 147.9% 42.0% 31.7%
Inventory Analysis
Closing Inventory Balance - 8 6 9 12
Closing Inventory as a % of Next Year Sales 0.0% 2.3% 1.4% 1.5% 1.8%
Average Inventory 4 7 7 10
Average Inventory as a % of Sales 1.6% 2.0% 1.6% 1.8%
9 Year Growth
Sales CAGR #DIV/0!
Gross Profit CAGR #DIV/0!
Net Profit CAGR #DIV/0!
5 Year Growth
Sales CAGR 16.6%
Gross Profit CAGR 16.1%
Net Profit CAGR 20.1%
Mar-15 Mar-16 Mar-17 Mar-18 Mar-19
100% 100% 100% 100% 100%
21% 22% 22% 0% 0%
0% 0% 0% 0% 0%
2% 2% 1% 1% 1%
6% 6% 13% 25% 25%
29% 29% 37% 26% 27%
71% 71% 63% 74% 73%
20% 17% 17% 17% 17%
25% 24% 18% 29% 28%
2% 3% 3% 3% 3%
2% 2% 3% 3% 4%
22% 24% 23% 22% 21%
4% 4% 3% 3% 3%
0% 0% 0% 0% 0%
21% 25% 26% 25% 25%
7% 9% 9% 8% 8%
15% 17% 17% 16% 17%
15-19
74.7%
TESTING:
This is a testing feature currently.
You can report any formula errors on the worksheet at: screener.feedback@dalal-street.in
… do ANYTHING.
alal-street.in
COMPANY NAME DR LAL PATHLABS LTD
LATEST VERSION 2.10 PLEASE
CURRENT VERSION 2.10
META
Number of shares 8.33
Face Value 10
Current Price 1567.9
Market Capitalization 13067.13
Quarters
Report Date Jun-17 Sep-17 Dec-17 Mar-18
Sales 249.30 278.10 262.70 266.80
Expenses 183.80 200.20 206.10 202.80
Other Income 7.50 7.70 7.10 8.90
Depreciation 6.90 7.50 8.00 10.70
Interest 0.10 0.30 0.20 0.20
Profit before tax 66.00 77.80 55.50 62.00
Tax 21.60 26.90 19.20 21.90
Net profit 44.10 50.60 36.30 40.00
Operating Profit 65.5 77.9 56.6 64
BALANCE SHEET
Report Date Mar-10 Mar-11 Mar-12 Mar-13
Equity Share Capital 3.39 3.35 3.36
Reserves 87.79 110.95 157.03
Borrowings 19.64 0.01 0.38
Other Liabilities 59.32 63.29 108.92
Total 170.14 177.60 269.69
Net Block 112.04 108.29 126.55
Capital Work in Progress 0.32 6.22 0.52
Investments 1.01 4.77 54.77
Other Assets 56.77 58.32 87.85
Total 170.14 177.60 269.69
Receivables 9.69 14.33 19.79
Inventory 7.75 6.23 8.63
Cash & Bank 22.46 13.44 21.46
No. of Equity Shares 339170 335448 335490
New Bonus Shares
Face value 100 100 100
CASH FLOW:
Report Date Mar-10 Mar-11 Mar-12 Mar-13
Cash from Operating Activity 41.78 68.13 88.13
Cash from Investing Activity -18.59 -26.26 -64.01
Cash from Financing Activity -22.15 -38.34 -14.79
Net Cash Flow 1.04 3.53 9.33
PRICE:
DERIVED:
Adjusted Equity Shares in Cr - 0.34 0.34 0.34
PLEASE DO NOT MAKE ANY CHANGES TO THIS SHEET
100 10 10 10 10 10